NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers

NCT01194934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: NOX-A12
DRUG: NOX-A12
DRUG: Filgrastim
DRUG: NOX-A12 in combination with Filgrastim

Sponsor

TME Pharma AG